MICHELLE N RHEAULT

Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Nephrology MINNEAPOLIS, MN NPI 1013053982

General Payments — all program years on this page

$15,340.12

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 20
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $7,932.13 across 11 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $6,496.002
Travel and Lodging $1,168.435
Food and Beverage $267.704

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Otsuka Pharmaceutical Development & Commercialization, Inc. $7,332.1310
Retrophin, Inc. $600.001

By program year

Program yearAmountRecords
2018 $1,502.253
2020 $2,449.002
2021 $1,750.001
2022 $600.001
2023 $1,106.742
2024 $7,932.1311

Records — PY2024 (11)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1118839329 Otsuka Pharmaceutical Development & Commercialization, Inc. $232.08 03/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118839331 Otsuka Pharmaceutical Development & Commercialization, Inc. $498.90 03/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118839333 Otsuka Pharmaceutical Development & Commercialization, Inc. $201.85 03/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118839335 Otsuka Pharmaceutical Development & Commercialization, Inc. $147.56 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118839337 Otsuka Pharmaceutical Development & Commercialization, Inc. $178.60 03/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118839339 Otsuka Pharmaceutical Development & Commercialization, Inc. $50.00 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118839341 Otsuka Pharmaceutical Development & Commercialization, Inc. $50.00 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118839343 Otsuka Pharmaceutical Development & Commercialization, Inc. $20.14 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118839345 Otsuka Pharmaceutical Development & Commercialization, Inc. $5,896.00 04/05/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1118839347 Otsuka Pharmaceutical Development & Commercialization, Inc. $57.00 04/05/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1149877280 Travere Therapeutics, Inc. $600.00 07/08/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.